Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Milon, Geneviève
and
Belkaid, Yasmine
1998.
Cytokines et infection.
Annales de l'Institut Pasteur / Actualités,
Vol. 9,
Issue. 2,
p.
107.
von Stebut, Esther
Belkaid, Yasmine
Jakob, Thilo
Sacks, David L.
and
Udey, Mark C.
1998.
Uptake of Leishmania major Amastigotes Results in Activation and Interleukin 12 Release from Murine Skin–derived Dendritic Cells: Implications for the Initiation of Anti-Leishmania Immunity .
The Journal of Experimental Medicine,
Vol. 188,
Issue. 8,
p.
1547.
Louis, Jacques A.
Conceiçao-Silva, Fatima
Himmelrich, Hayo
Tacchini-Cottier, Fabienne
and
Launois, Pascal
1998.
Mechanisms of Lymphocyte Activation and Immune Regulation VII.
Vol. 452,
Issue. ,
p.
53.
Noben-Trauth, Nancy
Paul, William E.
and
Sacks, David L.
1999.
IL-4- and IL-4 Receptor-Deficient BALB/c Mice Reveal Differences in Susceptibility to Leishmania major Parasite Substrains.
The Journal of Immunology,
Vol. 162,
Issue. 10,
p.
6132.
Kaufmann, S. H. E.
Khan, Imtiaz A.
and
Moretto, Magali
1999.
Role of Gamma Interferon in Cellular Immune Response against MurineEncephalitozoon cuniculiInfection.
Infection and Immunity,
Vol. 67,
Issue. 4,
p.
1887.
Mansfield, J. M.
Nicolas, Luc
Sidjanski, Sacha
Colle, Jean-Hervé
and
Milon, Geneviève
2000.
Leishmania majorReaches Distant Cutaneous Sites Where It Persists Transiently while Persisting Durably in the Primary Dermal Site and Its Draining Lymph Node: a Study with Laboratory Mice.
Infection and Immunity,
Vol. 68,
Issue. 12,
p.
6561.
Collins, Michael T.
Lisby, Gorm
Moser, Claus
Chicks, Debra
Christensen, Steen
Reichelderfer, Mark
Høiby, Niels
Harms, Bruce A.
Thomsen, Ole Ø.
Skibsted, Ulrik
and
Binder, Vibeke
2000.
Results of Multiple Diagnostic Tests forMycobacterium aviumsubsp.paratuberculosisin Patients with Inflammatory Bowel Disease and in Controls.
Journal of Clinical Microbiology,
Vol. 38,
Issue. 12,
p.
4373.
Launois, Pascal
Gumy, Alain
Himmelrich, Hayo
Locksley, Richard M.
Röcken, Martin
and
Louis, Jacques A.
2002.
Rapid IL-4 Production by Leishmania Homolog of Mammalian RACK1-Reactive CD4+ T Cells in Resistant Mice Treated Once with Anti-IL-12 or -IFN-γ Antibodies at the Onset of Infection with Leishmania major Instructs Th2 Cell Development, Resulting in Nonhealing Lesions.
The Journal of Immunology,
Vol. 168,
Issue. 9,
p.
4628.
Schmid-Hempel, Paul
2005.
Natural insect host-parasite systems show immune priming and specificity: puzzles to be solved.
BioEssays,
Vol. 27,
Issue. 10,
p.
1026.
Lang, Thierry
Goyard, Sophie
Lebastard, Mai
and
Milon, Genevieve
2005.
Bioluminescent Leishmania expressing luciferase for rapid and high throughput screening of drugs acting on amastigote-harbouring macrophages and for quantitative real-time monitoring of parasitism features in living mice.
Cellular Microbiology,
Vol. 7,
Issue. 3,
p.
383.
Rotureau, Brice
2006.
Are New World leishmaniases becoming anthroponoses?.
Medical Hypotheses,
Vol. 67,
Issue. 5,
p.
1235.
Nogueira, Marcia Ferraz
Goto, Hiro
Sotto, Mírian Nacagami
and
Cucé, Luiz Carlos
2008.
Cytokine profile in Montenegro skin test of patients with localized cutaneous and mucocutaneous leishmaniasis.
Revista do Instituto de Medicina Tropical de São Paulo,
Vol. 50,
Issue. 6,
p.
333.
Cuervo, Patricia
De Jesus, Jose B.
Saboia-Vahia, Leonardo
Mendonça-Lima, Leila
Domont, Gilberto B.
and
Cupolillo, Elisa
2009.
Proteomic characterization of the released/secreted proteins of Leishmania (Viannia) braziliensis promastigotes.
Journal of Proteomics,
Vol. 73,
Issue. 1,
p.
79.
Bertholet, Sylvie
Goto, Yasuyuki
Carter, Lauren
Bhatia, Ajay
Howard, Randall F.
Carter, Darrick
Coler, Rhea N.
Vedvick, Thomas S.
and
Reed, Steven G.
2009.
Optimized subunit vaccine protects against experimental leishmaniasis.
Vaccine,
Vol. 27,
Issue. 50,
p.
7036.
GOMES, D. C. O.
MUZITANO, M. F.
COSTA, S. S.
and
ROSSI-BERGMANN, B.
2010.
Effectiveness of the immunomodulatory extract of Kalanchoe pinnata against murine visceral leishmaniasis.
Parasitology,
Vol. 137,
Issue. 4,
p.
613.
Karam, Marc C.
Al-Kouba, Jane E.
Bazzi, Samer I.
Smith, Catherine B.
and
Leung, Lawrence
2011.
Interleukin-13 reduces hyperalgesia and the level of interleukin-1β in BALB/c mice infected with Leishmania major with an up-regulation of interleukin-6.
Journal of Neuroimmunology,
Vol. 234,
Issue. 1-2,
p.
49.
Matos, Ines
Mizenina, Olga
Lubkin, Ashira
Steinman, Ralph M.
Idoyaga, Juliana
and
Stager, Simona
2013.
Targeting Leishmania major Antigens to Dendritic Cells In Vivo Induces Protective Immunity.
PLoS ONE,
Vol. 8,
Issue. 6,
p.
e67453.
Mandell, Michael A.
Beverley, Stephen M.
and
Debrabant, Alain
2016.
Concomitant Immunity Induced by Persistent Leishmania major Does Not Preclude Secondary Re-Infection: Implications for Genetic Exchange, Diversity and Vaccination.
PLOS Neglected Tropical Diseases,
Vol. 10,
Issue. 6,
p.
e0004811.
Fermino, Marise L.
Dylon, L. Sebastian D.
Cecílio, Nerry T.
Santos, Sofia N.
Toscano, Marta A.
Dias-Baruffi, Marcelo
Roque-Barreira, Maria C.
Rabinovich, Gabriel A.
and
Bernardes, Emerson S.
2016.
Lack of galectin-3 increases Jagged1/Notch activation in bone marrow-derived dendritic cells and promotes dysregulation of T helper cell polarization.
Molecular Immunology,
Vol. 76,
Issue. ,
p.
22.
Mandell, Michael A.
and
Beverley, Stephen M.
2017.
Continual renewal and replication of persistentLeishmania majorparasites in concomitantly immune hosts.
Proceedings of the National Academy of Sciences,
Vol. 114,
Issue. 5,